Three teams shortlisted for the SOM Translational Team Science Awards

The Translational Team Science Awards program aims to capitalize on UNC-Chapel Hill’s culture of collaboration and foster interdisciplinary teams of scientific and clinical researchers.

The Translation Team Science Awards (TTSA) program provides funding to new teams of basic scientists and clinicians working to initiate innovative translational pilot projects aimed at building the infrastructure for future grant funding. Phase 1 teams receive $50,000 over a 12-month period to begin fully engaging team members in the development of a project and are eligible to submit a proposal for additional Phase 2 funding. TTSA ($75,000/1 year) upon completion of Phase 1 The SOM Research Office and NCTraCS jointly administer the program and are pleased to announce the most recent awards to the following three teams.

2021-22 TTSA Phase 1 Beneficiaries

Johanna Smeekens, PhD (Assistant Professor, Pediatrics) & Scott Commins, MD, Ph.D. (Associate Professor, Medicine, School of Medicine)
“Th2 asymmetry in early life as a risk factor for allergic sensitization”

Silvia Kreda, PhD (Associate Professor, Medicine and Biochemistry), Margaret Leigh, MD (Professor, Pediatrics) & Lawrence Ostrowski, Ph.D. (Professor, Pediatrics)
“Platform of oligonucleotide-based therapy and precision medicine for primary ciliary dyskinesia”

Brandi Reeves, MD (Assistant Professor, Medicine/Hematology) & Rafal Pawlinski, PhD (Professor, Medicine/Hematology, Faculty of Medicine)
“Alpha hypoxia-inducible factors in thrombosis associated with myeloproliferative neoplasm”

Comments are closed.